title: Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland.
authors.forename: Carsten
authors.initials: C
authors.lastname: Heinz
authors.forename: Hartmut
authors.initials: H
authors.lastname: Merz
authors.forename: Matthias
authors.initials: M
authors.lastname: Nieschalk
authors.forename: Heribert
authors.initials: H
authors.lastname: Mueller-Miny
authors.forename: Peter
authors.initials: P
authors.lastname: Koch
authors.forename: Arnd
authors.initials: A
authors.lastname: Heiligenhaus
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007766:Lacrimal Apparatus Diseases / Q000188:drug therapy*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab